104 related articles for article (PubMed ID: 3581187)
1. Reversible inhibition of microtubules and cell growth by the bicyclic colchicine analogue MTC.
Díez JC; Avila J; Nieto JM; Andreu JM
Cell Motil Cytoskeleton; 1987; 7(2):178-86. PubMed ID: 3581187
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis in leukemic cells by the reversible microtubule-disrupting agent 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1 -one: protection by Bcl-2 and Bcl-X(L) and cell cycle arrest.
Gajate C; Barasoain I; Andreu JM; Mollinedo F
Cancer Res; 2000 May; 60(10):2651-9. PubMed ID: 10825137
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic microtubules in human neutrophil degranulation: reversible inhibition by the colchicine analogue 2-methoxy-5-(2',3',4'-trimethoxyphenyl)-2,4,6-cycloheptatrien-1- one.
Mollinedo F; Nieto JM; Andreu JM
Mol Pharmacol; 1989 Oct; 36(4):547-55. PubMed ID: 2682203
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the colchicine binding site and the assembly of fish and mammalian microtubule proteins.
de Pereda JM; Wallin M; Billger M; Andreu JM
Cell Motil Cytoskeleton; 1995; 30(2):153-63. PubMed ID: 7606808
[TBL] [Abstract][Full Text] [Related]
5. Stoichiometric and substoichiometric inhibition of tubulin self-assembly by colchicine analogues.
Perez-Ramirez B; Andreu JM; Gorbunoff MJ; Timasheff SN
Biochemistry; 1996 Mar; 35(10):3277-85. PubMed ID: 8605164
[TBL] [Abstract][Full Text] [Related]
6. IKP104-induced decay of tubulin: role of the A-ring binding site of colchicine.
Chaudhuri AR; Tomita I; Mizuhashi F; Murata K; Potenziano JL; Ludueña RF
Biochemistry; 1998 Dec; 37(49):17157-62. PubMed ID: 9860828
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microtubules and cell cycle arrest by a new 1-deaza-7,8-dihydropteridine antitumor drug, CI 980, and by its chiral isomer, NSC 613863.
de Ines C; Leynadier D; Barasoain I; Peyrot V; Garcia P; Briand C; Rener GA; Temple C
Cancer Res; 1994 Jan; 54(1):75-84. PubMed ID: 8261466
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of tubulin-colchicine recognition--a kinetic study of the binding of a bicyclic colchicine analogue with a minor modification of the A ring.
Dumortier C; Potenziano JL; Bane S; Engelborghs Y
Eur J Biochem; 1997 Oct; 249(1):265-9. PubMed ID: 9363778
[TBL] [Abstract][Full Text] [Related]
9. Linkages in tubulin-colchicine functions: the role of the ring C (C') oxygens and ring B in the controls.
Pérez-Ramírez B; Gorbunoff MJ; Timasheff SN
Biochemistry; 1998 Feb; 37(6):1646-61. PubMed ID: 9484236
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of colchicine binding to tubulin. Tolerance of substituents in ring C' of biphenyl analogues.
Andreu JM; Gorbunoff MJ; Medrano FJ; Rossi M; Timasheff SN
Biochemistry; 1991 Apr; 30(15):3777-86. PubMed ID: 2015233
[TBL] [Abstract][Full Text] [Related]
11. A thermodynamic study of the interaction of tubulin with colchicine site ligands.
Menéndez M; Laynez J; Medrano FJ; Andreu JM
J Biol Chem; 1989 Oct; 264(28):16367-71. PubMed ID: 2777794
[TBL] [Abstract][Full Text] [Related]
12. The stabilization of microtubules in isolated spindles by tubulin-colchicine complex.
Hays TS; Salmon ED
Cell Motil Cytoskeleton; 1986; 6(3):282-90. PubMed ID: 3742623
[TBL] [Abstract][Full Text] [Related]
13. Colchicine analogues that bind reversibly to tubulin define microtubular requirements for newly synthesized protein secretion in rat lacrimal gland.
Herman G; Busson S; Gorbunoff MJ; Mauduit P; Timasheff SN; Rossignol B
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4515-9. PubMed ID: 2660140
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)-one.
Lin CM; Kang GJ; Roach MC; Jiang JB; Hesson DP; Luduena RF; Hamel E
Mol Pharmacol; 1991 Nov; 40(5):827-32. PubMed ID: 1944246
[TBL] [Abstract][Full Text] [Related]
15. Interaction of tubulin with octyl glucoside and deoxycholate. 2. Protein conformation, binding of colchicine ligands, and microtubule assembly.
Andreu JM; de la Torre J; Carrascosa JL
Biochemistry; 1986 Sep; 25(18):5230-9. PubMed ID: 3768343
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of association and dissociation of two enantiomers, NSC 613863 (R)-(+) and NSC 613862 (S)-(-) (CI 980), to tubulin.
Barbier P; Peyrot V; Dumortier C; D'Hoore A; Rener GA; Engelborghs Y
Biochemistry; 1996 Feb; 35(6):2008-15. PubMed ID: 8639685
[TBL] [Abstract][Full Text] [Related]
17. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
18. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
19. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
20. Interaction of tubulin and cellular microtubules with the new antitumor drug MDL 27048. A powerful and reversible microtubule inhibitor.
Peyrot V; Leynadier D; Sarrazin M; Briand C; Rodriquez A; Nieto JM; Andreu JM
J Biol Chem; 1989 Dec; 264(35):21296-301. PubMed ID: 2592375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
